UROLOGICAL CANCER | AUDITORIUM 2
See schedule

12 MAY 2017

UROLOGICAL CANCER | AUDITORIUM 2

Directors: Kris Maes, Francisco Mascarenhas

 

UROLOGICAL CANCER SESSION

The landscape of urological cancer with regards to diagnosis and management of the disease has undergone significant changes over the past decade.

Innovative imaging modalities available today provide opportunities to increase both diagnostic and prognostic accuracy and to improve treatment planning strategies.

The introduction of robotic surgery has greatly improved quality of care and clinical outcomes.

In addition, the use of emerging technologies in the field of radiotherapy and radio-immunotherapy, that provide an improved ability to precisely target and deliver radiation, has been rapidly expanding and evolving.